Navigation Links
Verenium Corporation to Announce Fourth Quarter and Year-End 2011 Financial Results
Date:2/27/2012

SAN DIEGO, Feb. 27, 2012 /PRNewswire/ -- Verenium Corporation (Nasdaq: VRNM), a leading industrial biotechnology company focused on the development and commercialization of high-performance enzymes, today announced that it will release 2011 fourth quarter and year-end financial results on Monday, March 5, 2012 at 8:00 a.m. ET. In conjunction with the release, the Company will host a conference call with live webcast on Monday, March 5 at 8:30 a.m. ET.

The call may be accessed by dialing 877-755-7422 (domestic) or 678-894-3067 (international) five minutes prior to start time and providing the passcode 56155577.  A link to the live webcast may be accessed by visiting the "Investors" section of the Company's website at http://www.verenium.com.  A replay of the event will be available on the Company's website approximately two hours after the call and will be archived for 30 days.

About Verenium
Verenium, an industrial biotechnology company, is a global leader in developing high-performance enzymes.  Verenium's tailored enzymes are environmentally friendly, making products and processes greener and more cost-effective for industries, including the global food and fuel markets.  Read more at www.verenium.com.

Forward-Looking Statements
Statements in this press release that are not strictly historical are "forward-looking" and involve a high degree of risk and uncertainty.  These include, but are not limited to, statements related to Verenium's lines of business, operations, capabilities, commercialization activities, corporate partnerships, target markets and future financial performance, results and objectives, all of which are prospective.  Such statements are only predictions, and actual events or results may differ materially
'/>"/>

SOURCE Verenium Corporation
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3

Related biology technology :

1. First Product Candidate Moving Toward Commercialization as Result of Novus International and Verenium Collaboration
2. Verenium to Present at Baird Clean Technology Conference
3. Verenium Reports Financial Results for the Third Quarter and Nine Months Ended September 30, 2011
4. Verenium Announces Up to $16 Million in New Secured Financings
5. Verenium Announces Debt Repurchase
6. Verenium to Present at Upcoming Conferences
7. Verenium Reports Financial Results for the Second Quarter and Six Months Ended June 30, 2011
8. Verenium Announces Debt Repurchase
9. Verenium Announces Signing of Lease for New Office and Lab Space
10. Verenium and Novus International Inc. Announce Agreement to Develop and Commercialize Animal Nutrition Enzymes
11. Verenium Receives CLARUS Award at MDB Capitals Bright Lights Conference 2011
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/17/2014)... 16, 2014 The Activated Carbon ... which is why IBISWorld updated its original industry research ... benefit from an intensified focus on environmental policy. Over ... emission standards for power plants and a range of ... IBISWorld Industry Analyst Sarah Kahn, “a range of downstream ...
(Date:12/17/2014)... Once more, EMAAR has selected ... waste water treatment plant to phase one of BayLaSun, ... Two years ago Bioshaft successfully supplied and operated a ... residential towers with an occupancy of 900 residences. ... gallons per day and was signed on September 16th, ...
(Date:12/17/2014)... 2014  Vermillion, Inc. (NASDAQ: VRML ), ... announced the next step in its expanded strategy to ... with the naming of current Chief Operating Officer, ... while current Chairman of the Board and CEO ... These changes are effective January 1, 2015. ...
(Date:12/15/2014)... METTLER TOLEDO is pleased to announce ... V19 with PVM technology , is now available. ... measurement tool continuously captures high-resolution images under a ... automatically prepares a report pairing the most relevant ... changes. This compelling blend of high resolution images ...
Breaking Biology Technology:Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 2Activated Carbon Manufacturing in the US Industry Market Research Report Has Been Updated from IBISWorld 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 2Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 3Vermillion Names Valerie Palmieri CEO; James LaFrance to continue as Chairman of Board 4New Real-Time In Situ Probe-Based Video Microscope from METTLER TOLEDO 2
... ... Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes, ... ATR-FTIR spectra for the production and control of qualitative supersaturation trajectories. , ... (PRWEB) October 9, 2009 -- ...
... PALO ALTO, Calif., Oct. 8 CardioDx, a cardiovascular ... G. Lange, M.D., Ph.D., as Chairman of the company,s ... first and only gene expression test to quantify the ... with stable chest pain. , "Dr. Lange brings ...
... WORTH, Texas, Oct. 8 Guacamole is a little ... and deli sections introduce Wholly "Pink" Guacamole. Nielsen-ranked, top-selling ... row, donating 15 percent of proceeds from October "PINK" ... pretty-in-pink box is a reminder of Texas-Based Wholly,s support ...
Cached Biology Technology:Calibration Free Supersaturation Assessment and Control for the Development and Optimization of Crystallization Processes 2CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors 2CardioDx Announces Appointment of Dr. Louis G. Lange as Chairman of the Board of Directors 3Grocery Produce Fighting for a Cause - Wholly 'Pink' Guacamole 2
(Date:12/10/2014)...  Wake Forest Baptist Medical Center today announced plans for ... Medicine. Funding for this $50 million capital project is ... publicly launched next summer. The medical ... series R.J. Reynolds Tobacco Company complex, adjacent to 525@vine ... with plans to be ready to welcome medical students ...
(Date:12/10/2014)... SUNNYVALE, California , December 9, 2014 /PRNewswire/ ... Integrate with ITN,s BCARD Platform ... secure, cloud-based enterprise meeting scheduling solutions for business-to-business ... International, the world leader in mobile near-field communication ... solutions.      (Logo: http://photos.prnewswire.com/prnh/20140612/691055) , ...
(Date:12/4/2014)... Fla. , Dec. 3, 2014  Crossmatch™, ... today announced that its DigitalPersona ® Pro ... readers have been deployed throughout First Bank branch ... South Carolina and Virginia. First ... Southern Pines, North Carolina , ...
Breaking Biology News(10 mins):Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 2Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 3Wake Forest Baptist to Build New Medical Education Facility In Wake Forest Innovation Quarter 4Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 2Jifflenow And ITN International Bring Cutting-Edge Badge Scanning Technology To B2B Events 3First Bank Partners with Crossmatch to Increase Log In Security 2First Bank Partners with Crossmatch to Increase Log In Security 3
... that the dawn of agriculture may have come with ... some 11,400 years ago, roughly a thousand years before ... in the region. The discovery dates domesticated figs to ... making the fruit trees the oldest known domesticated crop. ...
... combining the four bacterial surface proteins that generate ... the University of Chicago have created a vaccine ... drug-resistant strains of Staphylococcus aureus, the most common ... source of community-associated illness. , The vaccine ...
... June 15th issue of G&D, Dr. Marie-Louise Hammarskjold (UVA) ... the Wilms' Tumor 1 tumor suppressor. The Wilms' Tumor ... pathological human development, with known roles in kidney and ... , Dr. Hammarskjold and colleagues reveal that WT1 works ...
Cached Biology News:Tamed 11,400 years ago, figs were likely first domesticated crop 2MRSA vaccine shows promise in mouse study 2MRSA vaccine shows promise in mouse study 3
...
... III) from E. coli is an endoribonuclease ... dsRNA fragments that have 2-base, 3'-overhangs. ... fragments of 12-15 bp. RNase III ... ribonucleotides as well as DuraScript™ RNA, produced ...
Rabbit polyclonal to Peptide E ( Abpromise for all tested applications)....
Mouse monoclonal [6911] to E. coli K99 pilus ( Abpromise for all tested applications)....
Biology Products: